PD-L2 is a second ligand for PD-1 and inhibits T cell activationYvette Latchman, Gordon J. Freeman, Yoshiko Iwai et al.|Nature Immunology|2001Cited by 2.9k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidationNikolaos Patsoukis, Vassiliki A. Boussiotis|Nature Communications|2015Cited by 1.1k
The PD1:PD-L1/2 Pathway from Discovery to Clinical ImplementationKankana Bardhan, Vassiliki A. Boussiotis|Frontiers in Immunology|2016Cited by 596
Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia CellsJoão T. Barata, Vassiliki A. Boussiotis|The Journal of Experimental Medicine|2004Cited by 274
PD-1 Increases PTEN Phosphatase Activity While Decreasing PTEN Protein Stability by Inhibiting Casein Kinase 2Nikolaos Patsoukis, Vassiliki A. Boussiotis|Molecular and Cellular Biology|2013Cited by 186